Avenue Therapeutics Stock Analysis

Avenue Stock Analysis Notes

The company has price-to-book (P/B) ratio of 1.47. Some equities with similar Price to Book (P/B) outperform the market in the long run. Avenue Therapeutics recorded earning per share (EPS) of 24.78. The entity had not issued any dividends in recent years. The firm had 1:75 split on the 26th of April 2024. Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acuteintensive care hospital setting. The company was incorporated in 2015 and is based in New York, New York. Avenue Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. For more info on Avenue Therapeutics please contact the company at 781 652 4500 or go to https://www.avenuetx.com.

Avenue Therapeutics Investment Alerts

Avenue Therapeutics Upcoming and Recent Events

Avenue Largest EPS Surprises

View All Earnings Estimates

Avenue Therapeutics Environmental, Social, and Governance (ESG) Scores

Avenue Stock Institutional Investors

Note, although Avenue Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Avenue Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.84 M.

Avenue Profitablity

Management Efficiency

Avenue Therapeutics has return on total asset (ROA) of (2.0135) % which means that it has lost $2.0135 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.351) %, meaning that it created substantial loss on money invested by shareholders. Avenue Therapeutics' management efficiency ratios could be used to measure how well Avenue Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -5.89. The Avenue Therapeutics' current Return On Capital Employed is estimated to increase to -21.12. The Avenue Therapeutics' current Other Current Assets is estimated to increase to about 129.6 K, while Total Assets are projected to decrease to under 1.8 M.

Technical Drivers

As of the 22nd of November, Avenue Therapeutics shows the risk adjusted performance of (0.06), and Mean Deviation of 3.33. Avenue Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Avenue Therapeutics Price Movement Analysis

Avenue Therapeutics Insider Trading Activities

Avenue Therapeutics Outstanding Bonds

Avenue Therapeutics Predictive Daily Indicators

Avenue Therapeutics Corporate Filings

Avenue Therapeutics Forecast Models

Avenue Therapeutics' time-series forecasting models are one of many Avenue Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Avenue Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Avenue Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Avenue shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Avenue Therapeutics. By using and applying Avenue Stock analysis, traders can create a robust methodology for identifying Avenue entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Avenue analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Avenue analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Avenue Therapeutics stock analysis indicators help investors evaluate how Avenue Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Avenue Therapeutics shares will generate the highest return on investment. By understating and applying Avenue Therapeutics stock analysis, traders can identify Avenue Therapeutics position entry and exit signals to maximize returns.

When running Avenue Therapeutics' price analysis, check to measure Avenue Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avenue Therapeutics is operating at the current time. Most of Avenue Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avenue Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avenue Therapeutics' price. Additionally, you may evaluate how the addition of Avenue Therapeutics to your portfolios can decrease your overall portfolio volatility.